Tadalafil vs Sildenafil
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Cialis (tadalafil) and Viagra (sildenafil) are the two most recognized phosphodiesterase type 5 (PDE5) inhibitors [1][2] for treating erectile dysfunction (ED). Both medications work by enhancing the effects of nitric oxide, a natural chemical that relaxes smooth muscles in the penis, allowing increased blood flow during sexual stimulation.
Viagra, approved in 1998, was the first oral medication for ED and represented a breakthrough in the treatment of a condition affecting approximately 30 million men in the United States. Cialis, approved in 2003, entered the market with a key differentiating feature: a much longer duration of action that earned it the nickname "the weekend pill."
Both medications are FDA-approved for erectile dysfunction. Tadalafil (Cialis) [1] also holds FDA approvals for benign prostatic hyperplasia (BPH) and pulmonary arterial hypertension (under the brand name Adcirca). Sildenafil is approved for pulmonary arterial hypertension under the brand name Revatio.
This comparison reviews the evidence-based differences between these medications to help inform your discussion with a healthcare provider. ED can be a sign of underlying cardiovascular disease, so a medical evaluation is recommended before starting any ED medication.
Tadalafil vs Sildenafil: Side-by-side comparison
| Category | Tadalafil | Sildenafil |
|---|---|---|
| Generic Name | Tadalafil | Sildenafil |
| Brand Name | Cialis | Viagra |
| Drug Class | PDE5 Inhibitor | PDE5 Inhibitor |
| Duration of Action | Up to 36 hours | 4-6 hours |
| Onset of Action | 30-60 minutes | 30-60 minutes |
| Food Effect | None | Delayed by high-fat meals |
| Daily Dosing Option | Yes (2.5-5 mg) | No |
| Also Treats BPH | Yes | No |
| Visual Side Effects | Rare | 3-11% (blue tint) |
| Back Pain/Myalgia | 6-12% | Rare |
| Nitrate Washout | 48 hours | 24 hours |
| Cost Per Tablet (Generic) | $3-$15 | $2-$10 |
Efficacy: How well does each drug work?
Both Cialis and Viagra have demonstrated robust efficacy for erectile dysfunction in numerous randomized controlled trials. Overall response rates are similar, with approximately 65-80% of men reporting improved erections with either medication.
The most clinically significant difference is duration of action. Sildenafil (Viagra) has a duration of approximately 4-6 hours, while tadalafil (Cialis) lasts up to 36 hours. This extended window gives tadalafil a significant advantage in terms of spontaneity — patients do not need to plan sexual activity around medication timing as precisely.
Onset of action also differs. Sildenafil typically takes effect within 30-60 minutes and is significantly affected by food intake (particularly high-fat meals, which can delay onset by 1-2 hours). Tadalafil takes effect within 30-60 minutes but is not meaningfully affected by food, offering more flexibility.
Tadalafil is the only PDE5 inhibitor available in a daily dosing option (2.5 mg or 5 mg daily), which provides continuous readiness for sexual activity and eliminates the need for on-demand dosing entirely. This daily option also treats BPH symptoms, making it valuable for men with both ED and BPH.
For men who do not respond to one PDE5 inhibitor, switching to another is successful in approximately 50% of cases, suggesting that individual biochemistry plays a role in drug response.
Side effects comparison
Both medications share common PDE5 inhibitor side effects including headache, flushing, nasal congestion [1][2], dyspepsia [1][2], and dizziness. These are generally mild and transient.
Sildenafil is more likely to cause visual disturbances (blue-tinted vision, increased light sensitivity) due to its cross-reactivity with PDE6, an enzyme found in the retina. This occurs in approximately 3-11% of users and is dose-dependent. Tadalafil has minimal PDE6 activity and rarely causes visual changes.
Tadalafil is more likely to cause back pain and myalgia (muscle aches), occurring in approximately 6-12% of users. These effects are thought to be related to PDE11 inhibition and typically resolve within 48 hours. Sildenafil rarely causes these effects.
Both medications are contraindicated with nitrate medications (nitroglycerin, isosorbide) due to the risk of severe, potentially fatal hypotension. A washout period is needed before using nitrates: at least 24 hours after sildenafil, and at least 48 hours after tadalafil due to its longer half-life.
Rare but serious side effects shared by both include priapism [1][2] (painful erection lasting more than 4 hours — requires emergency treatment), sudden hearing loss, and non-arteritic anterior ischemic optic neuropathy (NAION). These are extremely rare.
Cost comparison
Both medications are available as generics, significantly reducing costs. Generic sildenafil [2] costs approximately $2-$10 per tablet (typical doses 25-100 mg). Generic tadalafil [1] costs approximately $3-$15 per tablet for on-demand use (5-20 mg).
Daily tadalafil (2.5 mg or 5 mg) costs approximately $30-$60 per month as a generic, making it an affordable option for men who prefer continuous dosing.
Brand-name Viagra and Cialis each cost $50-$80 per tablet, but are rarely dispensed due to generic availability. Most insurance plans do not cover ED medications, or limit coverage to a set number of tablets per month. GoodRx and similar discount programs can significantly reduce out-of-pocket costs at retail pharmacies.
Convenience and dosing
Tadalafil offers superior convenience in several ways. Its 36-hour duration means a single dose provides a much larger window for sexual activity compared to sildenafil's 4-6 hours. The daily dosing option eliminates timing considerations entirely.
Sildenafil must be taken on an empty stomach or after a light meal for optimal absorption. High-fat meals can delay onset by over an hour. Tadalafil can be taken regardless of food intake.
Both are available as oral tablets. Sildenafil is also available as a chewable tablet and oral suspension. Neither requires any monitoring or blood tests.
Which is right for you?
For men who prefer spontaneity [1][6] and do not want to plan sexual activity around medication timing, tadalafil (Cialis) may be the better choice due to its 36-hour duration and food-independent absorption. The daily dosing option is particularly advantageous for men in relationships with regular sexual activity or those who also have BPH symptoms.
For men who have infrequent sexual activity and prefer to take medication only when needed, sildenafil (Viagra) may be a cost-effective choice. Its shorter duration means side effects also resolve more quickly.
Men who experience back pain or myalgia with tadalafil may prefer sildenafil. Those who experience visual disturbances with sildenafil may prefer tadalafil. If one PDE5 inhibitor is ineffective, switching to the other is reasonable before concluding that PDE5 inhibitors do not work.
Both medications require sexual stimulation to work — they do not cause automatic erections. Both are contraindicated with nitrate medications. Discuss your medical history, current medications, and preferences with your healthcare provider.
Frequently asked questions
References
- [Regulatory] FDA. Cialis (tadalafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s020lbl.pdf Accessed 2025-01-15.
- [Regulatory] FDA. Viagra (sildenafil citrate) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s041lbl.pdf Accessed 2025-01-15.
- [Regulatory] Hatzimouratidis K, et al. Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation. Eur Urol. 2010;57(5):804-814. https://pubmed.ncbi.nlm.nih.gov/20189712/ Accessed 2025-01-15.
- [Regulatory] Brock GB, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12352386/ Accessed 2025-01-15.
- [Regulatory] Goldstein I, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580646/ Accessed 2025-01-15.
- [Clinical] Forgue ST, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61(3):280-288. https://pubmed.ncbi.nlm.nih.gov/16487221/ Accessed 2025-01-15.
- [Regulatory] American Urological Association. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/ Accessed 2025-01-15.
- [Regulatory] NIH. Erectile Dysfunction. https://www.niddk.nih.gov/health-information/urologic-diseases/erectile-dysfunction Accessed 2025-01-15.
- [Regulatory] Kloner RA, et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol. 2003;42(10):1855-1860. https://pubmed.ncbi.nlm.nih.gov/14642699/ Accessed 2025-01-15.
- [Clinical] Corona G, et al. Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction: the proper drug for the proper patient. J Sex Med. 2011;8(12):3418-3432. https://pubmed.ncbi.nlm.nih.gov/21995610/ Accessed 2025-01-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: